HOMEOPATHY FOR AUTOIMMUNE DISEASE, ITS IMMUNOMODULATORY POTENTIAL TARGETING IL-17A PATHWAYS TO ALLEVIATE INFLAMMATION

Abstract

Autoimmune diseases driven by IL-17A-mediated inflammation, such as psoriasis and rheumatoid arthritis, represent a significant therapeutic challenge. Conventional IL-17A inhibitors like secukinumab offer targeted relief but face limitations in accessibility and side effects. Homeopathy, through individualized remedies, demonstrates preliminary evidence of reducing pro-inflammatory cytokines, including those in the IL-17 axis, via immune modulation. This article reviews clinical studies and mechanisms supporting homeopathy's role in managing psoriasis, psoriatic arthritis (PsA), ankylosing spondylitis (AS), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), Sjögren's syndrome, systemic sclerosis, multiple sclerosis (MS), and inflammatory bowel disease (IBD) including Crohn's disease (CD) and ulcerative colitis (UC) [1][3][5].